Join
Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo
BioCryst Pharmaceuticals Inc. logo

BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management

ByQuantisnow·Wall Street's wire, on your screen.
RPRX· Royalty Pharma plcBCRX· BioCryst Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc), BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.

BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management | Quantisnow